eslicarbazepine acetate has been researched along with Deficiency, Mental in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allard, J; Ellawela, S; Henley, W; Hudson, S; Lawthom, C; Mclean, B; Pace, A; Rajakulendran, S; Shankar, R; Tittensor, P | 1 |
| Assenza, G; Boero, G; Chaves, J; Doherty, CP; McMurray, R; Rheims, S; Villanueva, V | 1 |
2 other study(ies) available for eslicarbazepine acetate and Deficiency, Mental
| Article | Year |
|---|---|
Eslicarbazepine acetate response in intellectual disability population versus general population.
Topics: Adult; Anticonvulsants; Dibenzazepines; Epilepsy; Female; Humans; Intellectual Disability; Male; Middle Aged; Prevalence; Retrospective Studies; Seizures | 2021 |
Eslicarbazepine acetate in epilepsy patients with psychiatric comorbidities and intellectual disability: Clinical practice findings from the Euro-Esli study.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Dibenzazepines; Epilepsy; Female; Humans; Intellectual Disability; Male; Mental Disorders; Middle Aged; Treatment Outcome; Young Adult | 2019 |